Physician profile
Thomas J Raley
NPI 1518967207
$4,716.04
in general payments reported to CMS, 2019-2025
9 companies · $291 in 2025
The $291 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,840 · 2020: $613 · 2021: $480 · 2022: $1,002 · 2023: $136 · 2024: $355 · 2025: $291.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $781.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $781.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $2,166.25 | 2021-2025 | Synchromedii, Intellis Adaptivestim, Inceptiv |
| Medtronic USA, INC. | $1,143.82 | 2019-2020 | |
| Abbott Laboratories | $687.35 | 2019-2020 | |
| Alevio, LLC | $501.15 | 2019-2020 | |
| Innovasis INC | $62.20 | 2020 | |
| Si-Bone, INC. | $60.65 | 2021 | |
| Nevro Corp. | $58.28 | 2019 | |
| Boston Scientific Corporation | $24.85 | 2021 | |
| Stimwave Technologies Incorporated | $11.49 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Raley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.